The UK NSC recommendation on mucopolysaccharidosis type I
Find general information about population health screening.
Why is screening not recommended by UK NSC?
More about MPS1
mucopolysaccharidosis type I (MPS I), also commonly known as Hurler's syndrome, is a rare, inherited condition that is part of a larger family called lysosomal storage disorders. In MPS1 the condition prevents the body's cells breaking down molecules such as proteins, carbohydrates and fats. The right levels of these molecules are essential to the functioning of organs such as the heart, lungs, skin, bones and tissues such as blood vessels and tendons.
In MPS I the unwanted build up of two carbohydrates can cause a wide range of health problems. It can also cause the early death of those affected. The effects of MPS I are not always the same and this has led to MPS1 often being split into two categories; a severe form and an 'attenuated' form, which is slower to develop and is sometimes quite mild.
• British Inherited Metabolic Disease Group
The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.
Recommendation Review History
The condition is being reviewed for the first time.
More optionsGo to top